B

bluebird bio
D

BLUE

8.49000
USD
-0.69
(-7.52%)
Market Closed
Volume
56,490
EPS
-31
Div Yield
-
P/E
-0
Market Cap
82,541,622
OverviewSignalsIdeasNews
Related Instruments
    A
    AKRO
    0.940
    (3.31%)
    29.330 USD
    B
    BHVN
    0.960
    (2.72%)
    36.270 USD
    B
    BPMC
    1.130
    (1.27%)
    90.120 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RARE
    0.770
    (1.77%)
    44.190 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: bluebird bio Inc

Sector: Healthcare
Industry: Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.